AJANTA PHARMA
Back to Balance Sheet
|
AJANTA PHARMA Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹33 Cr | ₹42 Cr | ₹41 Cr | ₹177 Cr | ₹285 Cr |
What is the latest Total Non-Current Liabilities ratio of AJANTA PHARMA ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2026 | ₹33 Cr |
| Mar2025 | ₹42 Cr |
| Mar2024 | ₹41 Cr |
| Mar2023 | ₹177 Cr |
| Mar2022 | ₹285 Cr |
How is Total Non-Current Liabilities of AJANTA PHARMA Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹33 Cr | -22.81 | |
| Mar2025 | ₹42 Cr | 3.21 | |
| Mar2024 | ₹41 Cr | -76.99 | |
| Mar2023 | ₹177 Cr | -37.77 | |
| Mar2022 | ₹285 Cr | - | |
Compare Total Non-Current Liabilities of peers of AJANTA PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AJANTA PHARMA | ₹44,358.8 Cr | -0.8% | -0.6% | 40% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹444,717.0 Cr | 1% | -3.3% | 13.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹255,115.0 Cr | 2.6% | 10.8% | 57.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹189,613.0 Cr | 2.7% | 0.3% | 39.6% | Stock Analytics | |
| CIPLA | ₹112,876.0 Cr | 2.4% | -1.1% | -12.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,395.0 Cr | 2.5% | 0.8% | -8.5% | Stock Analytics | |
AJANTA PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AJANTA PHARMA | -0.8% |
-0.6% |
40% |
| SENSEX | -0.5% |
-4.8% |
-11% |
You may also like the below Video Courses